Blog
RSS FeedPosted by Michael Wonder on 17 Oct 2022
ICER releases draft evidence report on treatments for multiple sclerosis
17 October 2022 - Public comment period now open until 11 November 2022; requests to make oral comment during public ...
Posted by Michael Wonder on 13 Oct 2022
HARmonized protocol template to enhance reproducibility of hypothesis evaluating real world evidence studies on treatment effects: a good practices report of a joint ISPE/ISPOR Task Force
12 October 2022 - Ambiguity in communication of key study parameters limits the utility of real-world evidence studies in health care ...
Posted by Michael Wonder on 11 Oct 2022
EMA publishes minutes of bilateral EMA – EUnetHTA meeting (June 2022)
11 October 2022 - The chairs welcome participants to the first bilateral under the new Work Plan between EUnetHTA 21 ...
Posted by Michael Wonder on 11 Oct 2022
ICER releases draft evidence report on treatment for vasomotor symptoms associated with menopause
11 October 2022 - Registration now open for October 19 “Early Insights” webinar. ...
Posted by Michael Wonder on 10 Oct 2022
EMA publishes agenda for 10-13 October 2022 CHMP meeting
10 October 2022 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 04 Oct 2022
2022 October price disclosure cycle – confirmed prices and patient savings reports
1 October 2022 - Combination flow-on reduction outcomes reflect confirmed 1 October 2022 prices on the Current Price Disclosure cycle web ...
Posted by Michael Wonder on 14 Sep 2022
Independent review of paracetamol overdose
14 September 2022 - The TGA has published an independent expert report examining the incidence of serious injury and death ...
Posted by Michael Wonder on 13 Sep 2022
ICER releases draft evidence report on gene therapies for haemophilia A and B
13 September 2022 - Registration now open for 20 September “Early Insights” webinar. ...
Posted by Michael Wonder on 13 Sep 2022
ICER publishes final evidence report and policy recommendations on treatments for amyotrophic lateral sclerosis
13 September 2022 - Majority of independent appraisal committee voted that evidence is adequate to demonstrate that both AMX0035 and oral ...
Posted by Michael Wonder on 12 Sep 2022
EMA publishes agenda for 12-15 September 2022 CHMP meeting
12 September 2022 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 09 Sep 2022
PBAC Public Summary Documents (first time rejections and deferrals) - May 2022 meeting
9 September 2022 - The Public Summary Documents (first time rejections and deferrals) from the May 2022 PBAC meeting are now ...
Posted by Michael Wonder on 08 Sep 2022
Submitting documents using real world data and real world evidence to FDA for drug and biological products
8 September 2022 - To facilitate FDA’s internal tracking of submissions to the Agency that include real world data and real ...
Posted by Michael Wonder on 05 Sep 2022
Review of Efficient Funding of Chemotherapy Program - interim report
5 September 2022 - The Efficient Funding of Chemotherapy review seeks to investigate current processes involved in the production, distribution ...
Posted by Michael Wonder on 02 Sep 2022
Updated agenda for the November 2022 PBAC meeting
2 September 2022 - The agenda for the November 2022 PBAC meeting has been updated. ...
Posted by Michael Wonder on 01 Sep 2022
ACE publishes another tranche of technology guidances (August 2022)
31 August 2022 - Six technology guidance documents were published yesterday. ...